Webcast

Watch the Full Meeting Live Webcast

A live webcast of the Cell & Gene Meeting on the Mediterranean will be available using the links below. Please check back on April 23 and 24 to stream the conference’s featured speakers, panels and company presentations.

If you can’t watch live, please note that videos of the meeting will be posted for playback two weeks after the close of the conference.

Gaudi 3

Gaudi 2

FULL LIVESTREAM AGENDA

9:00am | GENERAL SESSION – LIVESTREAM BEGINS

9:00am – 9:15am

WELCOME AND STATE OF THE INDUSTRY REMARKS {Gaudi 3}

Speaker:

Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine (ARM)

9:15am – 9:45am

KEYNOTE ADDRESS {Gaudi 3}

Speaker:

Guido Rasi, M.D., Director General, European Medicines Agency (EMA)

9:45am – 10:45am

PLENARY SESSION: COMMERCIAL STRATEGIES FROM PATHFINDERS IN THE INDUSTRY {Gaudi 3}

Chair:

Matthew Durdy, Chief Business Officer, Cell and Gene Therapy Catapult

Speakers:

Dan Faga, Chief Business Officer, Spark Therapeutics
Alison Finger, Chief Commercial Officer, bluebird bio
Claire Foreman, Head of Acute Programs, National Health Service
Owen Marks, Rare Disease Lead, Pfizer UK
Derrell Porter, M.D., SVP, Global Commercial Head, Atara Biotherapeutics
Pascal Touchon, SVP and Global Head, Cell and Gene, Novartis Oncology

10:45am – 11:15am | MORNING BREAK – NO LIVESTREAM AT THIS TIME

11:15am – 12:30pm | CONCURRENT TRACKS – LIVESTREAM RESUMES

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

COMPANY PRESENTATIONS {Gaudi 2}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

12:30pm – 1:45pm | LUNCH – NO LIVESTREAM AT THIS TIME

1:45pm – 3:30pm | CONCURRENT TRACKS – LIVESTREAM RESUMES

PANEL: THE PRICING AND REIMBURSEMENT LANDSCAPE: OPPORTUNITIES AND CHALLENGES  {Gaudi 3}
1:45pm – 2:45pm

Chair:
Tom Baker, VP, Life Science Strategy and Pricing and Market Access, IQVIA
Speakers:
Luca Alberici, Ph.D., Chief Business Officer, MolMed
Miguel Forte, M.D., Ph.D., CEO, Zelluna Immunotherapy
Etienne Jousseaume, Head of Market Access, Cell and Gene Europe, Novartis
Jason Meyenburg, Chief Commercial Officer, Orchard Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

1:45pm – 2:00pm
2:00pm – 2:15pm
2:15pm – 2:30pm
2:30pm – 2:45pm

COMPANY PRESENTATIONS {Gaudi 3}

2:45pm – 3:00pm
3:00pm – 3:15pm
3:15pm – 3:30pm

COMPANY PRESENTATIONS {Gaudi 2}

2:45pm – 3:00pm
3:00pm – 3:15pm
3:15pm – 3:30pm

3:30pm – 4:00pm | AFTERNOON BREAK – NO LIVESTREAM AT THIS TIME

4:00pm – 5:30pm | CONCURRENT TRACKS – LIVESTREAM RESUMES

SPOTLIGHT SESSION: CELL THERAPY FOR SOLID TUMORS {Gaudi 3}
4:00pm – 4:30pm

Chair:
Alexander Pasteur, Ph.D., Partner, F-Prime Capital
Speakers:
Usman Azam, M.D., President and CEO, Tmunity Therapeutics
Kimberly Freeman, VP, Commercial, Adaptimmune

COMPANY PRESENTATIONS {Gaudi 2}

4:00pm – 4:15pm
4:15pm – 4:30pm

PANEL: MANUFACTURING AND THE CDMO PERSPECTIVE {Gaudi 3}
4:30pm – 5:30pm

Chair:
Thomas Fellner, Ph.D., Global Head of Business Development and Account Management, Cell and Gene Technologies, Lonza
Speakers:
Catherine Cancian, VP, Pharmaceutical Operations, GenSight Biologics
Frédéric Revah, Ph.D., President, Yposkesi; CEO, Genethon
Joseph Tarnowski, Ph.D., SVP, Cell and Gene Therapy Platforms, Medicinal Science and Technology, R&D, GSK
Kim Warren, Head of Operations, AVROBIO

COMPANY PRESENTATIONS {Gaudi 2}

4:30pm – 4:45pm
4:45pm – 5:00pm
5:00pm – 5:15pm
5:15pm – 5:30pm

5:30pm | LIVESTREAM ENDS FOR THE DAY

9:00am | GENERAL SESSION – LIVESTREAM BEGINS

9:00am – 9:15am

WELCOME REMARKS {Gaudi 3}

Speaker:

Matthew Patterson, Chairman and CEO, Audentes Therapeutics; Chairman, Alliance for Regenerative Medicine (ARM)

9:15am – 10:45am | CONCURRENT TRACKS – LIVESTREAM CONTINUES

PANEL: RECENT DEVELOPMENTS AND PREDICTIONS FOR THE FUTURE OF ADVANCED THERAPIES  {Gaudi 3}
9:15am – 10:15am

Chair:
Morrie Ruffin, Co-Founder and Senior Advisor, Alliance for Regenerative Medicine (ARM)
Speakers:
Amy DuRoss, Co-Founder and CEO, Vineti
Sven Kili, M.D., Principal, Sven Kili Consulting
John Tchelingerian, Ph.D., President and CEO, Promethera Biosciences
Christopher Vann, Chief Operating Officer, Autolus Therapeutics
Rogerio Vivaldi, M.D., President and CEO, Sigilon Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

9:15am – 9:30am
9:30am – 9:45am
9:45am – 10:00am
10:00am – 10:15am

SPOTLIGHT SESSION: GENE EDITING: PARTNERING FOR SUCCESS {Gaudi 3}
10:15am – 10:45am

Chair:
Jessica Carmen, Ph.D., U.S. Business Development Advisor, Oxford BioMedica
Speakers:
Timothy Herpin, Ph.D., Chief Business Officer, Caribou Biosciences
Peter Nell, Ph.D., VP, Strategy and Business Development, Casebia Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

10:15am – 10:30am
10:30am – 10:45am

10:45am – 11:15am | MORNING BREAK – NO LIVESTREAM AT THIS TIME

11:15am – 12:30pm | CONCURRENT TRACKS – LIVESTREAM RESUMES

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

COMPANY PRESENTATIONS {Gaudi 2}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

12:30pm – 1:45pm | LUNCH – NO LIVESTREAM AT THIS TIME

1:45pm – 3:00pm | CONCURRENT TRACKS – LIVESTREAM RESUMES

PANEL: EUROPEAN CLINICAL TRIALS IN A GLOBAL CONTEXT {Gaudi 3}
1:45pm – 2:30pm

Chair:
Timothy Schroeder, CEO, CTI Clinical Trial & Consulting Services
Speakers:
Ian Hudson, M.D., Chief Executive, Medicines and Healthcare Products Regulatory Agency (MHRA)
Nathalie Morgensztejn, Head of Virology and Gene Therapy Department, French National Agency for Medicines and Health Products Safety (ANSM)
Ilona Reischl, Ph.D., Institute Surveillance, Federal Office for Safety in Health Care, Austrian Agency for Health and Food Safety
Martina Schüssler-Lenz, M.D., Chair, EMA Committee for Advanced Therapies, Paul-Ehrlich-Institut
Katsuaki Ura, Deputy Director, Office of International Regulatory Affairs, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare (MHLW)

COMPANY PRESENTATIONS {Gaudi 2}

1:45pm – 2:00pm
2:00pm – 2:15pm
2:15pm – 2:30pm

FIRESIDE CHAT: REGULATING ATMPs IN A POST BREXIT WORLD {Gaudi 3}
2:30pm – 3:00pm

Chair:
Keith Thompson, CEO, Cell and Gene Therapy Catapult
Speaker:
Ian Hudson, M.D., Chief Executive, Medicines and Healthcare Products Regulatory Agency (MHRA)

COMPANY PRESENTATIONS {Gaudi 2}

2:30pm – 2:45pm
2:45pm – 3:00pm

3:00pm – 3:30pm | AFTERNOON BREAK – NO LIVESTREAM AT THIS TIME

3:30pm – 4:30pm | CONCURRENT TRACKS – LIVESTREAM RESUMES

COMPANY PRESENTATIONS {Gaudi 3}

3:30pm – 3:45pm
3:45pm – 4:00pm
4:00pm – 4:15pm
4:15pm – 4:30pm

COMPANY PRESENTATIONS {Gaudi 2}

3:30pm – 3:45pm
3:45pm – 4:00pm
4:00pm – 4:15pm
4:15pm – 4:30pm

4:30pm | LIVESTREAM ENDS

By using this website you agree to accept our Privacy Policy and Terms & Conditions